iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $120.36 and last traded at $120.30, with a volume of 1110281 shares traded. The stock had previously closed at $119.15.
Separately, ValuEngine downgraded shares of iShares Nasdaq Biotechnology ETF from a “buy” rating to a “hold” rating in a research report on Tuesday, October 22nd.
The company’s fifty day simple moving average is $110.32 and its two-hundred day simple moving average is $105.71.
iShares Nasdaq Biotechnology ETF Company Profile (NASDAQ:IBB)
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.